CPIX
Cumberland Pharmaceuticals Inc
Nasdaq · usd
Cumberland Pharmaceuticals Inc (CPIX) trades at $4.87 (-42.60%) as of 2:05:21 PM EDT on Oct 26, 2026, -37.06% over the past month. Market cap is $127.21M, with 7.5 days to cover in short interest.
Stock performance
How Cumberland Pharmaceuticals Inc (CPIX) stock has performed from one day to one year, with its 52-week range.
- 1D
- -43.58%
- 1W
- -28.51%
- 1M
- -37.06%
- YTD
- +20.35%
- 1Y
- +50.16%
- 52-wk range
- $1.85 – $9.28
Key statistics
Today's trading snapshot for CPIX: day range, open, previous close, volume and market cap.
- Day range
- $4.79 – $7.76
- Open
- $7.76
- Prev close
- $8.49
- Volume
- 199.88K
- Market cap
- $127.21M
- Shares out
- 14.98M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Cumberland Pharmaceuticals Inc: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 4.07
- P/B
- 7.29
- P/FCF
- 186.00
- ROE
- -62.6%
- ROA
- -17.4%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events Cumberland Pharmaceuticals Inc has disclosed to the SEC on Form 8-K.
- Clinical trial resultsOct 23, 2026
On October 23, 2026, Cumberland Pharmaceuticals Inc. ("Cumberland") announced top-line results from its Phase 2a ASSIST-SSc trial evaluating oral ifetroban for patients with systemic sclerosis. These results support the safety and tolerability of ifetroban in this rare disease population.
- Clinical trial resultsAug 28, 2026
On June 26, 2026, Cumberland Pharmaceuticals Inc. presented data from its Phase 2 FIGHT DMD trial evaluating ifetroban, a novel oral therapy for Duchenne muscular dystrophy (DMD) heart disease, at the annual Parent Project Muscular Dystrophy conference in Orlando, Florida.
- Quarterly earningsAug 4, 2026
On August 4, 2026, Cumberland Pharmaceuticals Inc. (the "Company") issued a press release which provided a company update and the financial results for the three and six months ended June 30, 2026.
- Share repurchase programJul 13, 2026
the Board authorized an open-market share repurchase program of up to $5 million in Cumberland shares of common stock over time. This replaces the previous share repurchase program established in January 2019 that allowed $10 million of share repurchases, of which $2.1 million remained available.
- Executive officer departureJul 1, 2026
Effective July 31, 2026, in connection with the closing of the Transaction, Chris T. Bitterman, Vice President Sales & Marketing, and James L. Herman, Vice President Trade & Distribution and Corporate Compliance Officer, will resign from the Company and will be hired by an affiliate of Apotex.
Dividend history and stock splits
Cumberland Pharmaceuticals Inc's recent dividend payments and stock splits.
Dividends
- $1.50ex-div Aug 3, 2026
Splits
No recent splits.
CPIX short interest
How heavily CPIX is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 7.5
- Short interest
- 348.88K
- Avg volume
- 46.32K
As of · reported to FINRA twice monthly.
CPIX news
The latest news and headlines about Cumberland Pharmaceuticals Inc (CPIX).
- Hepatic Encephalopathy Market Analysis and Forecast, 2025-2035 - Key Players Shape the Market with Strategic Partnerships and Innovative TherapiesneutralGlobeNewswire Inc.· Nov 27, 2025
- RedHill Biopharma Receives Nasdaq Staff Determination NotificationneutralBenzinga· Oct 22, 2025
- Diffuse Cutaneous Systemic Sclerosis Market Forecast: Opportunities and Growth Trends Upto 2034 | DelveInsightpositiveGlobeNewswire Inc.· Oct 6, 2025
- Duchenne Muscular Dystrophy Market to Witness Significant Expansion During the Forecast Period (2025–2034) Amidst Advances in Gene Therapy and Novel Drug Approvals | DelveInsightpositiveGlobeNewswire Inc.· Jul 28, 2025
- Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsightpositiveGlobeNewswire Inc.· Jun 5, 2025
Frequently asked questions
What is the Cumberland Pharmaceuticals Inc (CPIX) stock price today?
Cumberland Pharmaceuticals Inc (CPIX) is trading at $4.87 (-42.60% on the day) as of 2:05:21 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Cumberland Pharmaceuticals Inc?
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products.
What is the short interest in CPIX?
As of Sep 30, 2026, CPIX has 348.88K shares short and 7.5 days to cover.
Does Cumberland Pharmaceuticals Inc (CPIX) pay a dividend?
Yes. Cumberland Pharmaceuticals Inc (CPIX)'s most recent dividend was $1.50 per share, with an ex-dividend date of Aug 3, 2026. Full CPIX dividend history is available from the Massive API.
What exchange is CPIX listed on?
Cumberland Pharmaceuticals Inc (CPIX) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of CPIX with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a CPIX analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.